Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 September 2022 | Story Gerda-Marié van Rooyen | Photo Supplied
Lisa Msiza
Lisa Nondumiso Msiza is the first Deaf person from the UFS to receive the prestigious Abe Bailey travel bursary.

Lisa Nondumiso Msiza is the first Deaf person from the UFS to receive the prestigious Abe Bailey Travel Bursary. This second-year student in Linguistics and Sign Language will visit the UK for three weeks, starting late November. Charity Morrison of the Centre for Universal Access and Disability Support (CUADS) will accompany her to interpret for her.

“I want to show through action that Deaf people can do anything. We have the required skills; we can read and write too – just like hearing people can. I would also like to make people aware that the UFS has the facilities to accommodate Deaf people,” says Lisa. Currently, 12 Deaf students are enrolled at this tertiary institution. 

This born Johannesburger’s passion for teaching and facilitating Sign Language is contagious. “I want to observe different businesses and programmes in the UK in order to learn how to start projects and develop myself and my community as Deaf people get limited opportunities. I want to teach people on the use, culture and history of Sign Language.” 

Lisa describes herself as a kind, understanding, and loving person. As she was born deaf, Sign Language is her home language. Her parents, however, are Zulu and Ndebele speaking. She says that, although Sign Language is different in every language, she quickly adapts and communicates in it as soon as she grasps the structure of the new language.

Being named top achiever (learner) for the 2020 matric class and being crowned in fifth position at the World Deaf Model 2021, Lisa is proof that beauty and brains can co-exist. 

“I am passionate about being a teacher, facilitator, or lecturer. I enjoy teaching others sign language so we can communicate more effectively. I love Sign Language and I am always trying to inform people on the importance of learning about Deaf people and to help others understand the nature of language and communication.” 

Her future dreams include becoming a lecturer at the UFS or to continue her studies abroad, but only to gain insight and benefit her community. “I want our country to prosper and would like to have every news bulletin interpreted for the Deaf.”

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept